Medication info
Ciroc Tablet 250 mg (Ciprofloxacin Hydrochloride Monohydrate)

Ciroc Tablet 250 mg (Ciprofloxacin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride Hydrate›291mg / 1 tablet
Manufacturer / importer
Korea United Pharm, Inc.
Appearance
White, round film-coated tablets
Packaging
For domestic use: 30 tablets/bottle, 100 tablets/bottle For export: 100 tablets/bottle, 100 tablets/PTP (10 tablets x 10)
Approval status
Active

MFDS item code 199001346 · Notified 1990.08.13 · Insurance code 644301980

Summary

Main use
Treatment of genitourinary, respiratory, otorhinolaryngological, and other infections (such as intestinal, skin, and eye infections)
Who takes it
Adults
Adult dose
(Tablets) ○ Usual adult dose: Administer 250 ~ 500 mg of ciprofloxacin per dose orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. For acute infections, treatment is usually given for 5 ~ 10 days and continued for at least 3 days after symptoms resolve. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients on hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formula. Men: {body weight(kg) × (140-age)}/ {72 × serum creatinine(mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment, but the patient's condition should be monitored carefully after administration. Adjust the dose appropriately according to symptoms.

Ingredients

Manufacturer
Korea United Pharm, Inc.

Efficacy & effects

Treatment of genitourinary, respiratory, otorhinolaryngological, and other infections (such as intestinal, skin, and eye infections)

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • chronic otitis media
  • bacterial prostatitis
  • acute uncomplicated cystitis
  • acute pyelonephritis
View approved original text

This medication is used to treat infections caused by various bacteria. It is effective against respiratory infections, with the exception of acute bronchitis, and community-acquired pneumonia. It is also used for infections of the ear, nose, and throat, bacterial prostatitis, acute urinary tract infections, gonococcal cervicitis, and urethritis. It aids in the treatment of gastrointestinal and biliary tract infections, skin and soft tissue infections, bone and joint infections, and gynecological infections. However, as a fluoroquinolone medication, it carries a risk of some serious side effects and is recommended to be used only when no alternative treatment methods are available for certain conditions. In summary, this medication is used safely and effectively for the treatment of various bacterial infections.

How to take

Adult dose

(Tablets) ○ Usual adult dose: Administer 250 ~ 500 mg of ciprofloxacin per dose orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. For acute infections, treatment is usually given for 5 ~ 10 days and continued for at least 3 days after symptoms resolve. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients on hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formula. Men: {body weight(kg) × (140-age)}/ {72 × serum creatinine(mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment, but the patient's condition should be monitored carefully after administration. Adjust the dose appropriately according to symptoms.

Precautions

This medication can cause serious side effects such as tendonitis, tendon rupture, peripheral neuropathy, central nervous system effects, and exacerbation of myasthenia gravis. If these symptoms occur, discontinue the medication immediately and consult a physician. Patients with a history of myasthenia gravis should avoid using this medication. This medication should only be used when there are no other treatment options for certain bacterial infections, and it should be avoided by women who are pregnant or breastfeeding, children under 18, and patients with epilepsy. Moreover, caution should be exercised when administering this medication to the elderly, patients with impaired renal function, and those with central nervous system disorders. During treatment, avoid excessive exposure to sunlight or ultraviolet light, and discontinue use immediately if photosensitivity occurs. Diabetic patients who require blood glucose control should closely monitor for changes in blood glucose levels and seek immediate treatment if hypoglycemic symptoms appear. This medication can interact with other drugs, so anyone taking other medications must inform their physician or pharmacist. Special caution is needed when taken with theophylline, warfarin, tizanidine, and ketoprofen. Dizziness or drowsiness may occur when driving or operating machinery, so exercise caution. This medication is primarily excreted through the kidneys, so patients with reduced kidney function may require dosage adjustments. In the case of overdose, appropriate emergency measures including renal function tests are necessary, and it should be stored out of reach of children.

Side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-related colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, reduced erythrocyte count, decreased hemoglobin, decreased hematocrit, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, inappropriate secretion of antidiuretic hormone syndrome, allergic reactions, allergic edema, angioedema, anaphylaxis, anaphylactoid reaction shock, serum sickness-like reaction, appetite loss, decreased food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory disturbances, sensory loss, taste loss, tremor, convulsions, vertigo, mental confusion, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, hypersensitivity, increased intracranial pressure, inability for coordinated movements, polyneuropathy, vision disturbances, color vision disturbances, diplopia, tinnitus, hearing loss, transient hearing loss, hearing damage, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, appetite suppression, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, pseudomembranous colitis, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tension and cramps, joint swelling, myasthenia, muscle weakness, partial or complete tendon rupture, renal impairment, increased BUN, increased serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undiagnosed pain, discomfort, fever, asthenia, edema, sweating, gait disturbances, maculopapular rash, purpuric rash, injection site rash, injection site itching, injection site urticaria, aneurysm, aortic dissection, cardiac valve regurgitation, cardiac valve insufficiency, muscle weakness, rhabdomyolysis, interstitial pneumonia, visual impairment

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that prevents contact with air and kept at a temperature between 1 and 30 degrees Celsius. This storage condition helps maintain the medication's effectiveness and prevents deterioration.

Appearance and packaging

Appearance

White, round film-coated tablets

Package unit

For domestic use: 30 tablets/bottle, 100 tablets/bottle For export: 100 tablets/bottle, 100 tablets/PTP (10 tablets x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.